Sarcoidosis is a multi-system disease of unknown etiology characterized by granuloma
formation in various organs (especially lung and mediastinohilar lymph nodes). In more than …

Use of third-line therapies in advanced sarcoidosis Page 1 Clinical and Experimental
Rheumatology 2020 Clinical and Experimental Rheumatology 2020; 38: 834-840. Use of third-line …

Introduction: Treatment of sarcoidosis recommendations are often based on clinical
experience and expert opinion. However, there are an increasing number of studies which …

Many advances have been made regarding sarcoidosis in the past 2 decades. As a result,
sarcoidosis is now defined as a multisystem disorder with a heightened cellular immune …

The options for treatment of sarcoidosis have expanded. In this article, we outline a stepwise
approach to treatment. Recommendations for treatment are based on available evidence …

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …

Introduction: Sarcoidosis is a systemic disease of unknown etiology characterized by the
development of non-caseating epitheloid granulomas. The lungs are the most commonly …

Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …

Corticosteroids remain the first-line therapy for sarcoidosis as many patients never require
treatment or only necessitate a short treatment duration. Second-line and third-line therapies …

Introduction: Care of patients with sarcoidosis requires familiarity with its natural history as
well as of various immunosuppressants employed in its treatment. We would like to share …